Hepatitis B Virus Dynamics: Modeling, Analysis, and Optimal Treatment Scheduling

Modeling, analysis, and control of hepatitis B virus (HBV) infection have attracted the interests of mathematicians during the recent years. Several mathematical models exist and adequately explain the HBV dynamics as well as the effect of antiviral drug therapies. However, none of these models can completely exhibit all that is observed clinically and account the full course of infection. Besides model inaccuracies that HBV dynamics models suffer from, some disturbances/uncertainties from different sources may arise in the modeling. In this paper, the HBV dynamics is described by a system of nonlinear ordinary differential equations. The disturbances or uncertainties are modeled in the HBV dynamics model as additive bounded disturbances. The model is incorporated with two types of drug therapies which are used to inhibit viral production and prevent new infections. The model can be considered as nonlinear control system with control input is defined to be dependent on the drug dose and drug efficiency. We developed treatment schedules for HBV infected patients by using multirate model predictive control (MPC). The MPC is applied to the stabilization of the uninfected steady state of the HBV dynamics model. The inherent robustness properties of the MPC against additive disturbances are also shown.

[1]  C. Gibbs,et al.  Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy , 1999, Hepatology.

[2]  Huan Qi,et al.  Mathematical Modeling of Cytotoxic Lymphocyte-Mediated Immune Response to Hepatitis B Virus Infection , 2008, Journal of biomedicine & biotechnology.

[3]  Global Properties of an Improved Hepatitis B Virus Model with Beddington-DeAngelis Infection Rate and CTL Immune Response , 2014 .

[4]  Yali Yang,et al.  Dynamical behaviors of an HBV infection model with logistic hepatocyte growth , 2011, Math. Comput. Model..

[5]  C. Vargas‐De‐León Analysis of a Model for the Dynamics of Hepatitis B with Noncytolytic Loss of Infected Cells , 2012 .

[6]  T. Yoneyama,et al.  Short and long period optimization of drug doses in the treatment of AIDS. , 2002, Anais da Academia Brasileira de Ciencias.

[7]  Rui Xu,et al.  An HBV model with diffusion and time delay. , 2009, Journal of theoretical biology.

[8]  Ahmed Elaiw,et al.  Global properties of a class of virus infection models with multitarget cells , 2012 .

[9]  Ryan Zurakowski,et al.  A model predictive control based scheduling method for HIV therapy. , 2006, Journal of theoretical biology.

[10]  I. A. Hassanien,et al.  GLOBAL STABILITY OF HIV INFECTION MODELS WITH INTRACELLULAR DELAYS , 2012 .

[11]  S. Bonhoeffer,et al.  HIV-1 Evolution and Disease Progression , 1996, Science.

[12]  Kaifa Wang,et al.  Global properties of an improved hepatitis B virus model , 2010 .

[13]  R. Xu,et al.  Asymptotic Properties of a Hepatitis B Virus Infection Model with Time Delay , 2010 .

[14]  E. Gyurkovics,et al.  A STABILIZING SAMPLED-DATA '¡ STEP RECEDING HORIZON CONTROL WITH APPLICATION TO A HIV/AIDS , 2006 .

[15]  A. Elaiw Global Dynamics of an HIV Infection Model with Two Classes of Target Cells and Distributed Delays , 2012 .

[16]  C. Vargas‐De‐León,et al.  Stability analysis of a model for HBV infection with cure of infected cells and intracellular delay , 2012 .

[17]  Jianhua Pang,et al.  The importance of immune responses in a model of hepatitis B virus , 2012 .

[18]  S. Amir Ghoreishi,et al.  Antiviral therapy using a fuzzy controller optimized by modified evolutionary algorithms: a comparative study , 2012, Neural Computing and Applications.

[19]  A. Neumann,et al.  Global stability and periodic solution of the viral dynamics , 2007 .

[20]  R. Xu,et al.  MATHEMATICAL ANALYSIS OF AN IMPROVED HEPATITIS B VIRUS MODEL , 2012 .

[21]  David Q. Mayne,et al.  Constrained model predictive control: Stability and optimality , 2000, Autom..

[22]  A. M. Elaiw,et al.  Global Properties of Virus Dynamics Models with Multitarget Cells and Discrete-Time Delays , 2011 .

[23]  Martin A Nowak,et al.  Mathematical models of HIV pathogenesis and treatment. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[24]  A. Elaiw,et al.  HIV dynamics: Analysis and robust multirate MPC-based treatment schedules , 2008 .

[25]  A. Elaiw Global properties of a class of HIV models , 2010 .

[26]  M A Nowak,et al.  Viral dynamics in hepatitis B virus infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Elaiw,et al.  Global properties of a class of HIV infection models with Beddington–DeAngelis functional response , 2013 .

[28]  Kaifa Wang,et al.  Dynamics of an HBV model with diffusion and delay. , 2008, Journal of theoretical biology.

[29]  M. Nowak,et al.  Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.

[30]  W. Shao-li,et al.  Global asymptotical properties for a diffused HBV infection model with CTL immune response and nonlinear incidence , 2011 .

[31]  S. Amir Ghoreishi,et al.  Application of covariance matrix adaptation–evolution strategy to optimal control of hepatitis B infection , 2012, Neural Computing and Applications.

[32]  Lequan Min,et al.  Mathematical Analysis of a Basic Virus Infection Model With Application to HBV Infection , 2008 .

[33]  Éva Gyurkovics,et al.  Stabilization of sampled-data nonlinear systems by receding horizon control via discrete-time approximations , 2003, Autom..

[34]  Kaifa Wang,et al.  Propagation of HBV with spatial dependence. , 2007, Mathematical biosciences.

[35]  Stanca M. Ciupe,et al.  Modeling the mechanisms of acute hepatitis B virus infection. , 2007, Journal of theoretical biology.

[36]  A. Elaiw Multirate sampling and input-to-state stable receding horizon control for nonlinear systems , 2007 .

[37]  A. Elaiw,et al.  Stability and Feedback Stabilization of HIV Infection Model with Two Classes of Target Cells , 2012 .

[38]  J. Craggs Applied Mathematical Sciences , 1973 .

[39]  Redouane Qesmi,et al.  Influence of backward bifurcation in a model of hepatitis B and C viruses. , 2010, Mathematical biosciences.

[40]  A. Obaid,et al.  Global analysis of a virus infection model with multitarget cells and distributed intracellular delays , 2012 .

[41]  M. Yuen,et al.  The Natural History and Treatment of Chronic Hepatitis B: A Critical Evaluation of Standard Treatment Criteria and End Points , 2007, Annals of Internal Medicine.

[42]  K. Hattaf,et al.  Optimal Control of Treatment in a Basic Virus Infection Model , 2009 .

[43]  Suxia Zhang,et al.  The analysis and application of an HBV model , 2012 .

[44]  Alan S. Perelson,et al.  Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed , 2001, Hepatology.

[45]  Alan S. Perelson,et al.  Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy , 1998 .